Damora Therapeutics, Inc. (DMRA) quarterly income statement — complete revenue, gross profit & net income history
Damora Therapeutics, Inc. (DMRA) annual income statement — 8-year revenue, gross profit & net income history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 11K | 68K | 0 | 0 | 0 | 0 | 5K | 60K | 77K | 98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -11K | -68K | 0 | 0 | 0 | 0 | -5K | -60K | -77K | -98K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 100% | 100% | 100% | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 36.86M | 34.98M | 30.74M | 201.7M | 3.16M | 3.42M | 2.6M | 2.7M | 3.78M | 4.53M | 5.64M | 6.67M | 8.58M | 11.16M | 13.49M | 13.53M | 13.62M | 17.12M | 16.94M | 13.47M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.39M | 9.44M | 7.03M | 4.07M | 1.74M | 1.96M | 1.92M | 1.69M | 2.69M | 2.7M | 3.18M | 3.18M | 3.3M | 3.07M | 3.13M | 2.75M | 3.13M | 3.41M | 3.7M | 3.35M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 25.48M | 25.54M | 23.78M | 197.63M | 1.42M | 1.47M | 678K | 1.01M | 1.09M | 1.83M | 2.46M | 2.77M | 2.55M | 8.09M | 10.36M | 10.77M | 10.49M | 13.71M | 13.23M | 10.12M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 720K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -36.86M | -34.99M | -30.81M | -201.7M | -3.16M | -3.42M | -2.6M | -2.71M | -3.84M | -4.61M | -5.74M | -6.67M | -8.58M | -11.16M | -13.49M | -13.53M | -13.62M | -17.12M | -16.94M | -13.47M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -1068.03% | -922.92% | -1085.49% | -7350.91% | 17.81% | 25.78% | - | - | - | - | 57.45% | 50.68% | 36.99% | 34.82% | 20.35% | -0.42% | -5.28% | -39.56% | -24.99% | -19.16% |
| EBITDA | -36.6M | -34.98M | -30.74M | -201.69M | -3.15M | -3.41M | -2.59M | -2.7M | -3.78M | -4.53M | -5.64M | -6.44M | -8.22M | -11.06M | -13.35M | -13.36M | -13.52M | -17.02M | -16.82M | -13.36M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -1063.35% | -925.29% | -1086.53% | -7364.43% | 16.77% | 24.71% | - | - | - | - | 57.74% | 51.79% | 39.22% | 34.98% | 20.62% | -0.03% | -5.44% | -40% | -25.04% | -18.73% |
| D&A (Non-Cash Add-back) | 264K | 11K | 68K | 7K | 10K | 9K | 8K | 5K | 60K | 77K | 98K | 229K | 367K | 95K | 139K | 164K | 104K | 104K | 118K | 111K |
| EBIT | -36.86M | -34.99M | -27.74M | -200.69M | -3.13M | -3.43M | -2.53M | -6.75M | -3.88M | -5.3M | -5.48M | -5.95M | -5.86M | -11.16M | -13.49M | -13.53M | -13.62M | -17.12M | -16.94M | -13.47M |
| Net Interest Income | 4.16M | 4.06M | 3.07M | 1M | 42K | 50K | 74K | 228K | 146K | 213K | 257K | 340K | 473K | 442K | 434K | 284K | 221K | 156K | 61K | 30K |
| Interest Income | 4.16M | 4.06M | 3.07M | 1M | 42K | 50K | 74K | 228K | 146K | 213K | 257K | 340K | 473K | 442K | 434K | 284K | 221K | 156K | 61K | 30K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 4.87M | 4.08M | 3.07M | 1M | 23K | -12K | 68K | -4.04M | -36K | -687K | 264K | 196K | 447K | 415K | 498K | -544K | -108K | 234K | 1K | 59K |
| Pretax Income | -31.99M | -30.92M | -27.74M | -200.69M | -3.13M | -3.43M | -2.53M | -6.75M | -3.88M | -5.3M | -5.48M | -6.47M | -8.14M | -10.74M | -12.99M | -14.07M | -13.73M | -16.89M | -16.94M | -13.41M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 255K | 42K | 44K | 0 | 4K | 2K | -8K | 7K | 42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -0.82% | -0.15% | -0.02% | 0% | -0.12% | -0.08% | 0.12% | -0.18% | -0.79% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -31.99M | -31.17M | -27.78M | -200.74M | -3.13M | -3.44M | -2.53M | -6.74M | -3.88M | -5.34M | -5.48M | -6.47M | -8.14M | -10.74M | -12.99M | -14.07M | -13.73M | -16.89M | -16.94M | -13.41M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -921.1% | -807.01% | -996.84% | -2877.84% | 19.31% | 35.61% | - | - | - | - | 57.85% | 53.98% | 40.74% | 36.38% | 23.28% | -4.92% | -8.14% | -37.27% | -26.92% | -15.82% |
| Net Income (Continuing) | -31.99M | -31.17M | -27.78M | -200.74M | -3.13M | -3.44M | -2.53M | -6.74M | -3.88M | -5.34M | -5.48M | -6.47M | -8.14M | -10.74M | -12.99M | -14.07M | -13.73M | -16.89M | -16.94M | -13.41M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.40 | -0.51 | -0.81 | -121.10 | -2.36 | -2.60 | -1.92 | -5.22 | -3.39 | -4.92 | -5.10 | -5.97 | -7.50 | -10.18 | -12.11 | -14.25 | -13.57 | -16.71 | -16.76 | -13.27 |
| EPS Growth % | 83.05% | 80.38% | 57.81% | -2219.92% | 30.38% | 47.15% | - | - | - | - | 57.89% | 58.11% | 44.73% | 39.08% | 27.74% | -7.39% | -8.04% | -37.3% | -26.87% | -15.79% |
| EPS (Basic) | -0.40 | -0.51 | -0.81 | -121.10 | -2.36 | -2.60 | -1.92 | -5.22 | -3.39 | -4.92 | -5.10 | -5.97 | -7.50 | -10.18 | -12.11 | -14.25 | -13.57 | -16.71 | -16.76 | -13.27 |
| Diluted Shares Outstanding | 16.37M | 61.14M | 34.3M | 1.66M | 1.33M | 1.32M | 1.32M | 1.29M | 1.14M | 1.08M | 1.07M | 1.08M | 1.08M | 1.06M | 1.03M | 1.03M | 1.02M | 1.01M | 1.01M | 1.01M |
| Basic Shares Outstanding | 16.37M | 61.14M | 34.3M | 1.66M | 1.33M | 1.32M | 1.32M | 1.29M | 1.14M | 1.08M | 1.07M | 1.08M | 1.08M | 1.06M | 1.03M | 1.03M | 1.02M | 1.01M | 1.01M | 1.01M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |